Discount Agreement for Fesoterodin
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fesoterodin, ATC G04BD11 für die Zeit 01.08.2026 - 31.07.2028 (zzgl. Verlängerungsoption 1x12 Monate)
DAK-Gesundheit is entering into non-exclusive discount agreements for the active ingredient Fesoterodin. This allows all interested pharmaceutical companies to participate from August 2026 to July 2028 (with an extension option).
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- SomeTenderDocID1NON-RESTRICTED-DOCUMENT
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.